1. Newton, Axel H, Pask, Andrew J. 2020. CHD9 upregulates RUNX2 and has a potential role in skeletal evolution. In BMC molecular and cell biology, 21, 27. doi:10.1186/s12860-020-00270-5. https://pubmed.ncbi.nlm.nih.gov/32295522/
2. Ooga, Masatoshi, Funaya, Satoshi, Hashioka, Yuki, Suzuki, Masataka G, Aoki, Fugaku. 2018. Chd9 mediates highly loosened chromatin structure in growing mouse oocytes. In Biochemical and biophysical research communications, 500, 583-588. doi:10.1016/j.bbrc.2018.04.105. https://pubmed.ncbi.nlm.nih.gov/29665362/
3. Song, Dan, Zhang, Qian, Zhang, Hao, Zhan, Liangliang, Sun, Xinchen. 2022. MiR-130b-3p promotes colorectal cancer progression by targeting CHD9. In Cell cycle (Georgetown, Tex.), 21, 585-601. doi:10.1080/15384101.2022.2029240. https://pubmed.ncbi.nlm.nih.gov/35100082/
4. Guan, Bo, Ran, Xian-Gui, Du, Yong-Qiang, Wang, Ying, Chen, Ming-Min. 2018. High CHD9 expression is associated with poor prognosis in clear cell renal cell carcinoma. In International journal of clinical and experimental pathology, 11, 3697-3702. doi:. https://pubmed.ncbi.nlm.nih.gov/31949752/
5. Yoo, Hyunjin, La, Hyeonwoo, Lee, Eun Joo, Thang, Nguyen Xuan, Hong, Kwonho. 2020. ATP-Dependent Chromatin Remodeler CHD9 Controls the Proliferation of Embryonic Stem Cells in a Cell Culture Condition-Dependent Manner. In Biology, 9, . doi:10.3390/biology9120428. https://pubmed.ncbi.nlm.nih.gov/33261017/